Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Goudreau

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Practical Radiation Oncology|November 18, 2024
Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast CancerAmbrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical TrialAsal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|October 28, 2021
Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Ambrosia Simmons, D Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2022
In Reply to Hannoun-Levi et alAsal Rahimi, Ambrosia Simmons, D Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
NPJ Breast Cancer|December 10, 2020
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIALWen Li, David C Newitt, Jessica Gibbs, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Practical Radiation Oncology|November 18, 2024
Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast CancerAmbrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical TrialAsal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|October 28, 2021
Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Ambrosia Simmons, D Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2022
In Reply to Hannoun-Levi et alAsal Rahimi, Ambrosia Simmons, D Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
NPJ Breast Cancer|December 10, 2020
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIALWen Li, David C Newitt, Jessica Gibbs, et al.
Pageof 2